BREAKING: An independent FDA advisory panel voted unanimously to authorize Moderna Covid-19 vaccine boosters for Americans 65 and older, anyone 18 and older with underlying conditions and those frequently exposed to the virus.
The U.S. Food and Drug Administration is reviewing data from drug companies to determine when a booster shot is necessary.An independent Food and Drug Administration advisory panel on Thursday voted unanimously to authorize Modernaboosters for Americans 65 and older, anyone 18 and older with underlying conditions and those frequently exposed to the virus.
Dr. Jacqueline Miller, who presented Moderna's data Thursday, said the company chose the half dose because it was just as effective but would"increase the worldwide vaccine supply of mRNA." Also on Friday, the outside experts will then consider new data from the National Institutes of Health on the potential benefits of mixing and matching vaccines for booster shots.finds that boosting with a shot different from what people got the first time appears to be safe and effective.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
FDA panel debates lower-dose Moderna COVID shots for boosterU.S. health advisers are debating if millions of Americans who received Moderna vaccinations should get a booster shot -- this time, using half the original dose. Already millions who got their initial Pfizer shots at least six months ago are getting a booster of that brand.
Baca lebih lajut »
COVID-19 Live Updates: FDA to hold crunch talks over J&J and Moderna vaccine boostersThe Food and Drug Administration is set to hold crucial meetings over the next two days to decide whether to issue booster shots of Johnson & Johnson and Moderna COVID vaccines. Follow Newsweek's liveblog for all the latest.
Baca lebih lajut »
FDA advisory group recommends Moderna booster for emergency useJUST IN: FDA advisory panel votes to recommend Moderna booster shots for emergency use authorization for certain at-risk groups.
Baca lebih lajut »
FDA Neutral on Moderna Bid for Booster Ahead of Decisive MeetingThe FDA is keeping its cards close to the vest when it comes to the potential approval of a booster dose of Moderna’s COVID-19 vaccine.
Baca lebih lajut »
FDA to take up Moderna, J&J Covid-19 booster questions this weekVaccine advisers to the FDA meet Thursday and Friday of this week to tackle the next round of questions about booster vaccines for Covid-19 — and they might be seeing the first trickle of data on mix-and-match boosters.
Baca lebih lajut »
FDA Staff Don’t Take Position on Moderna Covid-19 BoosterIn an unusual move, FDA staff didn't take a position on Moderna's application for a booster shot, indicating there may be insufficient data to support one
Baca lebih lajut »